Cell Therapy for Heart Disease: Great Expectations, As Yet Unmet

Heart Lung and Circulation

Volumn 18, Issue 4, 2009, Pages 245-256

  Stamm, Christof ^a,c   Nasseri, Boris ^a   Choi, Yeong Hoon ^b   Hetzer, Roland ^a,c  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

Author keywords

Cell therapy; Heart failure; Myocardial infarction; Regeneration; Stem cells

Indexed keywords

ACUTE HEART INFARCTION; AGE; CARDIAC STEM CELL; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CLINICAL TRIAL; EMBRYONIC STEM CELL; FUNDING; GOVERNMENT REGULATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MONONUCLEAR CELL; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL MOBILIZATION; TISSUE REGENERATION;

BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 67651055208     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.10.014     Document Type: Review

References (96)

1. Messina E., De Angelis L., Frati G., Morrone S., Chimenti S., Fiordaliso F., Salio M., Battaglia M., Latronico M.V., Coletta M., Vivarelli E., Frati L., Cossu G., and Giacomello A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
2. Rota M., Hosoda T., De Angelis A., Arcarese M.L., Esposito G., Rizzi R., Tillmanns J., Tugal D., Musso E., Rimoldi O., Bearzi C., Urbanek K., Anversa P., Leri A., and Kajstura J. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res 101 (2007) 387-399
3. Bittmann I., Hentrich M., Bise K., Kolb H.J., and Lohrs U. Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation. J Hematother Stem Cell Res 12 (2003) 359-366
4. Deb A., Wang S., Skelding K.A., Miller D., Simper D., and Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 107 (2003) 1247-1249
5. Jiang S., Walker L., Afentoulis M., Anderson D.A., Jauron-Mills L., Corless C.L., and Fleming WH. Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A 101 (2004) 16891-16896
6. Minami E., Laflamme M.A., Saffitz J.E., and Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112 (2005) 2951-2958
7. Laflamme M.A., Myerson D., Saffitz J.E., and Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90 (2002) 634-640
8. Torella D., Ellison G.M., Karakikes I., and Nadal-Ginard B. Resident cardiac stem cells. Cell Mol Life Sci 64 (2007) 661-673
9. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
10. Oh H., Bradfute S.B., Gallardo T.D., Nakamura T., Gaussin V., Mishina Y., Pocius J., Michael L.H., Behringer R.R., Garry D.J., Entman M.L., and Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A 100 (2003) 12313-12318
11. Bearzi C., Rota M., Hosoda T., Tillmanns J., Nascimbene A., De Angelis A., Yasuzawa-Amano S., Trofimova I., Siggins R.W., Lecapitaine N., Cascapera S., Beltrami A.P., D'Alessandro D.A., Zias E., Quaini F., Urbanek K., Michler R.E., Bolli R., Kajstura J., Leri A., and Anversa P. Human cardiac stem cells. Proc Natl Acad Sci U S A 104 (2007) 14068-14073
12. Smith R.R., Barile L., Cho H.C., Leppo M.K., Hare J.M., Messina E., Giacomello A., Abraham M.R., and Marban E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
13. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., Lin L.Z., Cai C.L., Lu M.M., Reth M., Platoshyn O., Yuan J.X., Evans S., and Chien KR. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433 (2005) 647-653
14. Chiu R.C., Zibaitis A., and Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg 60 (1995) 12-18
15. Marelli D., Desrosiers C., el-Alfy M., Kao R.L., and Chiu RC. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant 1 (1992) 383-390
16. Leor J., Patterson M., Quinones M.J., Kedes L.H., and Kloner RA. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat. A potential method for repair of infarcted myocardium?. Circulation 94 (1996) II332-336
17. Taylor D.A., Atkins B.Z., Hungspreugs P., Jones T.R., Reedy M.C., Hutcheson K.A., Glower D.D., and Kraus WE. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat Med 4 (1998) 929-933
18. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., Schwartz K., Vilquin J.T., and Marolleau JP. Myoblast transplantation for heart failure. Lancet 357 (2001) 279-280
19. Rubart M., Soonpaa M.H., Nakajima H., and Field L.J. Spontaneous and evoked intracellular calcium transients in donor-derived myocytes following intracardiac myoblast transplantation. J Clin Invest 114 (2004) 775-783
20. Dib N., Michler R.E., Pagani F.D., Wright S., Kereiakes D.J., Lengerich R., Binkley P., Buchele D., Anand I., Swingen C., Di Carli M.F., Thomas J.D., Jaber W.A., Opie S.R., Campbell A., McCarthy P., Yeager M., Dilsizian V., Griffith B.P., Korn R., Kreuger S.K., Ghazoul M., MacLellan W.R., Fonarow G., Eisen H.J., Dinsmore J., and Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 112 (2005) 1748-1755
21. Limana F., Zacheo A., Mocini D., Mangoni A., Borsellino G., Diamantini A., De Mori R., Battistini L., Vigna E., Santini M., Loiaconi V., Pompilio G., Germani A., and Capogrossi MC. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ Res 101 (2007) 1255-1265
22. Behfar A., Zingman L.V., Hodgson D.M., Rauzier J.M., Kane G.C., Terzic A., and Puceat M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J 16 (2002) 1558-1566
23. Dai W., Field L.J., Rubart M., Reuter S., Hale S.L., Zweigerdt R., Graichen R.E., Kay G.L., Jyrala A.J., Colman A., Davidson B.P., Pera M., and Kloner RA. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 43 (2007) 504-516
24. Menard C., Hagege A.A., Agbulut O., Barro M., Morichetti M.C., Brasselet C., Bel A., Messas E., Bissery A., Bruneval P., Desnos M., Puceat M., and Menasche P. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet 366 (2005) 1005-1012
25. Behfar A., Perez-Terzic C., Faustino R.S., Arrell D.K., Hodgson D.M., Yamada S., Puceat M., Niederlander N., Alekseev A.E., Zingman L.V., and Terzic A. Cardiopoietic programming of embryonic stem cells for tumor-free heart repair. J Exp Med 204 (2007) 405-420
26. Byrne J.A., Pedersen D.A., Clepper L.L., Nelson M., Sanger W.G., Gokhale S., Wolf D.P., and Mitalipov SM. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450 (2007) 497-502
27. Guan K., Wagner S., Unsold B., Maier L.S., Kaiser D., Hemmerlein B., Nayernia K., Engel W., and Hasenfuss G. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 100 (2007) 1615-1625
28. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
29. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
30. Kim J.B., Zaehres H., Wu G., Gentile L., Ko K., Sebastiano V., Arauzo-Bravo M.J., Ruau D., Han D.W., Zenke M., and Scholer H.R. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454 (2008) 646-650
31. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., Yamanaka S., and Yamashita J.K. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118 (2008) 498-506
32. Pasumarthi K.B., and Field L.J. Cardiomyocyte cell cycle regulation. Circ Res 90 (2002) 1044-1054
33. Soonpaa M.H., and Field L.J. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 272 (1997) H220-226
34. Soonpaa M.H., Koh G.Y., Pajak L., Jing S., Wang H., Franklin M.T., Kim K.K., and Field L.J. Cyclin d1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 99 (1997) 2644-2654
35. Pasumarthi K.B., Nakajima H., Nakajima H.O., Soonpaa M.H., and Field L.J. Targeted expression of cyclin d2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 96 (2005) 110-118
36. Chaudhry H.W., Dashoush N.H., Tang H., Zhang L., Wang X., Wu E.X., and Wolgemuth D.J. Cyclin a2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem 279 (2004) 35858-35866
37. Cheng R.K., Asai T., Tang H., Dashoush N.H., Kara R.J., Costa K.D., Naka Y., Wu E.X., Wolgemuth D.J., and Chaudhry H.W. Cyclin a2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res 100 (2007) 1741-1748
38. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., and Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
39. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., Pickel J., McKay R., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
40. Murry C.E., Soonpaa M.H., Reinecke H., Nakajima H., Nakajima H.O., Rubart M., Pasumarthi K.B., Virag J.I., Bartelmez S.H., Poppa V., Bradford G., Dowell J.D., Williams D.A., and Field L.J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
41. Rota M., Kajstura J., Hosoda T., Bearzi C., Vitale S., Esposito G., Iaffaldano G., Padin-Iruegas M.E., Gonzalez A., Rizzi R., Small N., Muraski J., Alvarez R., Chen X., Urbanek K., Bolli R., Houser S.R., Leri A., Sussman M.A., and Anversa P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104 (2007) 17783-17788
42. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., and Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 (1968) 230-247
43. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
44. Le Blanc K., and Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 262 (2007) 509-525
45. Makino S., Fukuda K., Miyoshi S., Konishi F., Kodama H., Pan J., Sano M., Takahashi T., Hori S., Abe H., Hata J., Umezawa A., and Ogawa S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103 (1999) 697-705
46. Hattan N., Kawaguchi H., Ando K., Kuwabara E., Fujita J., Murata M., Suematsu M., Mori H., and Fukuda K. Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res 65 (2005) 334-344
47. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
48. Ma N., Stamm C., Kaminski A., Li W., Kleine H.D., Muller-Hilke B., Zhang L., Ladilov Y., Egger D., and Steinhoff G. Human cord blood cells induce angiogenesis following myocardial infarction in nod/scid-mice. Cardiovasc Res 66 (2005) 45-54
49. Ma N., Ladilov Y., Moebius J.M., Ong L., Piechaczek C., David A., Kaminski A., Choi Y.H., Li W., Egger D., Stamm C., and Steinhoff G. Intramyocardial delivery of human cd133+ cells in a scid mouse cryoinjury model: Bone marrow vs cord blood-derived cells. Cardiovasc Res 71 (2006) 158-169
50. Prat-Vidal C., Roura S., Farre J., Galvez C., Llach A., Molina C.E., Hove-Madsen L., Garcia J., Cinca J., and Bayes-Genis A. Umbilical cord blood-derived stem cells spontaneously express cardiomyogenic traits. Transplant Proc 39 (2007) 2434-2437
51. Li W., Ma N., Ong L.L., Nesselmann C., Klopsch C., Ladilov Y., Furlani D., Piechaczek C., Moebius J.M., Lutzow K., Lendlein A., Stamm C., Li R.K., and Steinhoff G. Bcl-2 engineered mscs inhibited apoptosis and improved heart function. Stem Cells 25 (2007) 2118-2127
52. Mangi A.A., Noiseux N., Kong D., He H., Rezvani M., Ingwall J.S., and Dzau V.J. Mesenchymal stem cells modified with akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9 (2003) 1195-1201
53. Westenbrink B.D., Lipsic E., van der Meer P., van der Harst P., Oeseburg H., Du Marchie Sarvaas G.J., Koster J., Voors A.A., van Veldhuisen D.J., van Gilst W.H., and Schoemaker R.G. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur Heart J 28 (2007) 2018-2027
54. Spyridopoulos I., Haendeler J., Urbich C., Brummendorf T.H., Oh H., Schneider M.D., Zeiher A.M., and Dimmeler S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor trf2 in endothelial progenitor cells. Circulation 110 (2004) 3136-3142
55. Sasaki K., Heeschen C., Aicher A., Ziebart T., Honold J., Urbich C., Rossig L., Koehl U., Koyanagi M., Mohamed A., Brandes R.P., Martin H., Zeiher A.M., and Dimmeler S. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial no synthase enhancer ave9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci U S A 103 (2006) 14537-14541
56. Maurel A., Azarnoush K., Sabbah L., Vignier N., Le Lorc'h M., Mandet C., Bissery A., Garcin I., Carrion C., Fiszman M., Bruneval P., Hagege A., Carpentier A., Vilquin J.T., and Menasche P. Can cold or heat shock improve skeletal myoblast engraftment in infarcted myocardium?. Transplantation 80 (2005) 660-665
57. Hu X., Yu S.P., Fraser J.L., Lu Z., Ogle M.E., Wang J.A., and Wei L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg 135 (2008) 799-808
58. Aicher A., Heeschen C., Sasaki K., Urbich C., Zeiher A.M., and Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: a new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 114 (2006) 2823-2830
59. Nurzynska D., Di Meglio F., Castaldo C., Arcucci A., Marlinghaus E., Russo S., Corrado B., de Santo L., Baldascino F., Cotrufo M., and Montagnani S. Shock waves activate in vitro cultured progenitors and precursors of cardiac cell lineages from the human heart. Ultrasound Med Biol 34 (2008) 334-342
60. Robey T.E., Saiget M.K., Reinecke H., and Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45 (2008) 567-581
61. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., and Drexler H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the boost randomised controlled clinical trial. Lancet 364 (2004) 141-148
62. Assmus B., Fischer-Rasokat U., Honold J., Seeger F.H., Fichtlscherer S., Tonn T., Seifried E., Schachinger V., Dimmeler S., and Zeiher A.M. Transcoronary transplantation of functionally competent bmcs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the topcare-chd registry. Circ Res 100 (2007) 1234-1241
63. Assmus B., Honold J., Schachinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., Teupe C., Pistorius K., Martin H., Abolmaali N.D., Tonn T., Dimmeler S., and Zeiher A.M. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
64. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., Van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., and Van de Werf F. Autologous bone marrow-derived stem-cell transfer in patients with st-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367 (2006) 113-121
65. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J.G., Smith H.J., Taraldsrud E., Grogaard H.K., Bjornerheim R., Brekke M., Muller C., Hopp E., Ragnarsson A., Brinchmann J.E., and Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
66. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., Yu J., Corti R., Mathey D.G., Hamm C.W., Suselbeck T., Assmus B., Tonn T., Dimmeler S., and Zeiher A.M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 (2006) 1210-1221
67. Lunde K., Solheim S., Aakhus S., Arnesen H., Moum T., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., and Forfang K. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: results from the autologous stem cell transplantation in acute myocardial infarction (astami) randomized controlled trial. Am Heart J 154 710 (2007) e711-718
68. Abdel-Latif A., Bolli R., Tleyjeh I.M., Montori V.M., Perin E.C., Hornung C.A., Zuba-Surma E.K., Al-Mallah M., and Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
69. Perin E.C., Dohmann H.F., Borojevic R., Silva S.A., Sousa A.L., Silva G.V., Mesquita C.T., Belem L., Vaughn W.K., Rangel F.O., Assad J.A., Carvalho A.C., Branco R.V., Rossi M.I., Dohmann H.J., and Willerson J.T. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 (2004) II213-218
70. Brehm M., and Strauer B.E. Stem cell therapy in postinfarction chronic coronary heart disease. Nat Clin Pract Cardiovasc Med 3 Suppl. 1 (2006) S101-S104
71. Galinanes M., Loubani M., Davies J., Chin D., Pasi J., and Bell P.R. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant 13 (2004) 7-13
72. Povsic T.J., Zavodni K.L., Kelly F.L., Zhu S., Goldschmidt-Clermont P.J., Dong C., and Peterson E.D. Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50 (2007) 2243-2248
73. Erbs S., Linke A., Adams V., Lenk K., Thiele H., Diederich K.W., Emmrich F., Kluge R., Kendziorra K., Sabri O., Schuler G., and Hambrecht R. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 97 (2005) 756-762
74. Patel A.N., Geffner L., Vina R.F., Saslavsky J., Urschel Jr. H.C., Kormos R., and Benetti F. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 130 (2005) 1631-1638
75. Stamm C., Kleine H.D., Westphal B., Petzsch M., Kittner C., Nienaber C.A., Freund M., and Steinhoff G. Cabg and bone marrow stem cell transplantation after myocardial infarction. Thorac Cardiovasc Surg 52 (2004) 152-158
76. Stamm C., Westphal B., Kleine H.D., Petzsch M., Kittner C., Klinge H., Schumichen C., Nienaber C.A., Freund M., and Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
77. Stamm C., Kleine H.D., Choi Y.H., Dunkelmann S., Lauffs J.A., Lorenzen B., David A., Liebold A., Nienaber C., Zurakowski D., Freund M., and Steinhoff G. Intramyocardial delivery of cd133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
78. Losordo D.W., Schatz R.A., White C.J., Udelson J.E., Veereshwarayya V., Durgin M., Poh K.K., Weinstein R., Kearney M., Chaudhry M., Burg A., Eaton L., Heyd L., Thorne T., Shturman L., Hoffmeister P., Story K., Zak V., Dowling D., Traverse J.H., Olson R.E., Flanagan J., Sodano D., Murayama T., Kawamoto A., Kusano K.F., Wollins J., Welt F., Shah P., Soukas P., Asahara T., and Henry T.D. Intramyocardial transplantation of autologous cd34+ stem cells for intractable angina: a phase i/iia double-blind, randomized controlled trial. Circulation 115 (2007) 3165-3172
79. Amado L.C., Saliaris A.P., Schuleri K.H., St John M., Xie J.S., Cattaneo S., Durand D.J., Fitton T., Kuang J.Q., Stewart G., Lehrke S., Baumgartner W.W., Martin B.J., Heldman A.W., and Hare J.M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102 (2005) 11474-11479
80. Grinnemo K.H., Mansson A., Dellgren G., Klingberg D., Wardell E., Drvota V., Tammik C., Holgersson J., Ringden O., Sylven C., and Le Blanc K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 127 (2004) 1293-1300
81. American college of cardiology. First human trial tests stem-cell-based treatment for heart attacks. Sciencedaily. 28 March 2007. Retrieved September 26, 2008, from http://209.85.135.104/search?Q=cache:2bht8k26ug0j:Www.Sciencedaily.Com/releases/2007/03/070326121246.Htm+american+college+of+cardiology+innovation+in+intervention:+i2+summit+hare&hl=de&ct=clnk&cd=2&gl=de.
82. Texas Heart Institute. World's first adult stem cell study using patient's own fat tissue. Sciencedaily. 7 February 2007. Retrieved September 26, 2008, from http://www.Sciencedaily.Com/releases/2007/02/070206161744.Htm.
83. Orlic D., Kajstura J., Chimenti S., Limana F., Jakoniuk I., Quaini F., Nadal-Ginard B., Bodine D.M., Leri A., and Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
84. Ince H., Stamm C., and Nienaber C.A. Cell-based therapies after myocardial injury. Curr Treat Options Cardiovasc Med 8 (2006) 484-495
85. Pompilio G., Cannata A., Peccatori F., Bertolini F., Nascimbene A., Capogrossi M.C., and Biglioli P. Autologous peripheral blood stem cell transplantation for myocardial regeneration: a novel strategy for cell collection and surgical injection. Ann Thorac Surg 78 (2004) 1808-1812
86. Nasseri B.A., Kukucka M., Dandel M., Knosalla C., Potapov E., Lehmkuhl H.B., Meyer R., Ebell W., Stamm C., and Hetzer R. Intramyocardial delivery of bone marrow mononuclear cells and mechanical assist device implantation in patients with end-stage cardiomyopathy. Cell Transplant 16 (2007) 941-949
87. Messas E., Bel A., Morichetti M.C., Carrion C., Handschumacher M.D., Peyrard S., Vilquin J.T., Desnos M., Bruneval P., Carpentier A., Menasche P., Levine R.A., and Hagege A.A. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. J Am Coll Cardiol 47 (2006) 2086-2093
88. Klein H.M., Ghodsizad A., Borowski A., Saleh A., Draganov J., Poll L., Stoldt V., Feifel N., Piecharczek C., Burchardt E.R., Stockschlader M., and Gams E. Autologous bone marrow-derived stem cell therapy in combination with tmlr. A novel therapeutic option for endstage coronary heart disease: report on 2 cases. Heart Surg Forum 7 (2004) E416-E419
89. Sherman W., Martens T.P., Viles-Gonzalez J.F., and Siminiak T. Catheter-based delivery of cells to the heart. Nat Clin Pract Cardiovasc Med 3 Suppl. 1 (2006) S57-S64
90. Yau T.M., Kim C., Ng D., Li G., Zhang Y., Weisel R.D., and Li R.K. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 80 (2005) 1779-1786
91. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., and Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33 (2001) 907-921
92. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., and Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
93. Kraitchman D.L., Heldman A.W., Atalar E., Amado L.C., Martin B.J., Pittenger M.F., Hare J.M., and Bulte J.W. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107 (2003) 2290-2293
94. Mayhew T.M., Pharaoh A., Austin A., and Fagan D.G. Stereological estimates of nuclear number in human ventricular cardiomyocytes before and after birth obtained using physical dissectors. J Anat 191 Pt 1 (1997) 107-115
95. Stamm C., Nasseri B., Drews T., and Hetzer R. Cardiac cell therapy: a realistic concept for elderly patients?. Exp Gerontol 43 (2008) 679-690
96. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16ink4a. Nature 443 (2006) 421-426